Education
About Us
Working with TipRanks
Follow Us
Inogen (INGN)
NASDAQ:INGN
INGN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.14 - $13.33
Previous CloseN/A
Volume110.44K
Average Volume (3M)367.77K
Market Cap
$180.40M
Enterprise Value$120.66M
Total Cash (Recent Filing)-$15.11M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.88
Next Earnings
May 01, 2025EPS Estimate
-0.44Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.52
Shares Outstanding26,529,545
10 Day Avg. Volume304,659
30 Day Avg. Volume367,774
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.58
Price to Cash Flow (P/CF)-16.20
P/FCF Ratio0.00
Enterprise Value/Market Cap0.67
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.78
Enterprise Value/Ebitda-3.93
Forecast
1Y Price Target
$10.00Price Target Upside47.06% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
---
Inogen News
PremiumCompany Announcements
Inogen Inc’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Inogen Reports Strong Revenue Growth in 2024
PremiumCompany Announcements
Inogen Board Reshuffle with Sahney Appointment---
Bulls Say, Bears Say
Bulls Say
PartnershipsThe strategic agreement with Yuwell is expected to further reaccelerate U.S. direct-to-consumer sales.
Regulatory ApprovalINGN announced that its SIMEOX 200 airway clearance device received a 510(k) clearance from the FDA.
Revenue GrowthINGN's B2B sales beat estimates due to new customer wins, increased business from existing customers, and further share gains from Philips.
Bears Say
Direct-to-Consumer SalesDirect-to-consumer sales missed estimates due to a decline in sales rep headcount.
ProfitabilityINGN's EBITDA and EPS remained negative despite improvements in margins.
---
Ownership Overview
1.77% Insiders
16.39% Mutual Funds
27.23% Other Institutional Investors
44.41% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INGN FAQ
What was Inogen’s price range in the past 12 months?
Inogen lowest stock price was $6.14 and its highest was $13.33 in the past 12 months.
What is Inogen’s market cap?
Inogen’s market cap is $180.40M.
When is Inogen’s upcoming earnings report date?
Inogen’s upcoming earnings report date is May 01, 2025 which is in 30 days.
How were Inogen’s earnings last quarter?
Inogen released its earnings results on Feb 25, 2025. The company reported -$0.41 earnings per share for the quarter, beating the consensus estimate of -$0.608 by $0.198.
Is Inogen overvalued?
According to Wall Street analysts Inogen’s price is currently Undervalued.
Does Inogen pay dividends?
Inogen does not currently pay dividends.
What is Inogen’s EPS estimate?
Inogen’s EPS estimate is -0.44.
How many shares outstanding does Inogen have?
Inogen has 26,529,545 shares outstanding.
What happened to Inogen’s price movement after its last earnings report?
Inogen reported an EPS of -$0.41 in its last earnings report, beating expectations of -$0.608. Following the earnings report the stock price went down -14.811%.
Which hedge fund is a major shareholder of Inogen?
Currently, no hedge funds are holding shares in INGN
---
Inogen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (47.06% Upside)
$10.00 (47.06% Upside)
Blogger Sentiment
Bullish
INGN Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 274.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $125.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 4.4%
Last 30 Days ▼ 4.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-15.73%
12-Months-Change
Fundamentals
Return on Equity
-18.95%
Trailing 12-Months
Asset Growth
-9.20%
Trailing 12-Months
Company Description
Inogen
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
---
INGN Company Deck
---
INGN Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Inogen's earnings call highlighted notable achievements in revenue growth, strategic collaborations, and product innovations, contributing positively to the company's outlook. However, challenges remain with declines in direct-to-consumer and rental revenues, alongside a continued net loss. The positive aspects, especially strategic partnerships and product clearances, suggest optimism for future growth.Read More>---
INGN Stock 12 Month Forecast
Average Price Target
$10.00
▲(47.06% Upside)
Technical Analysis
Boston Scientific
―
Orthofix
―
Zimmer Biomet Holdings
―
Nevro Corp
―
TransMedics Group
―
Best Analysts Covering INGN
1 Year
1 Year Success Rate
12/18 ratings generated profit
1 Year Average Return
+26.17%
reiterated a sell rating 5 months ago
Copying Robbie Marcus's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +26.17% per trade.
---